Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Assuntos: ESQUIZOFRENIA, GLUTAMATOS, CLÍNICAS (EXPERIMENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, C. et al. Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update. Brazilian Journal of Medical and Biological Research, v. 42, n. 11, p. , 2009Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2009001100002. Acesso em: 30 set. 2024.APA
Chaves, C., Marque, C. R. de, Hallak, J. E. C., Sousa, J. P. M. de, Zuardi, A. W., Crippa, J. A. de S., et al. (2009). Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update. Brazilian Journal of Medical and Biological Research, 42( 11), . doi:10.1590/s0100-879x2009001100002NLM
Chaves C, Marque CR de, Hallak JEC, Sousa JPM de, Zuardi AW, Crippa JA de S, Dursun SM, Trzesniak C. Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update [Internet]. Brazilian Journal of Medical and Biological Research. 2009 ; 42( 11): .[citado 2024 set. 30 ] Available from: https://doi.org/10.1590/s0100-879x2009001100002Vancouver
Chaves C, Marque CR de, Hallak JEC, Sousa JPM de, Zuardi AW, Crippa JA de S, Dursun SM, Trzesniak C. Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update [Internet]. Brazilian Journal of Medical and Biological Research. 2009 ; 42( 11): .[citado 2024 set. 30 ] Available from: https://doi.org/10.1590/s0100-879x2009001100002
